| Clinical data | |
|---|---|
| Trade names | Trocoxil |
| AHFS/Drugs.com | International Drug Names |
| ATCvet code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.248.948 |
| Chemical and physical data | |
| Formula | C16H11F4N3O2S |
| Molar mass | 385.34 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Mavacoxib (trade nameTrocoxil) is aveterinary drug used to treat pain and inflammation in dogs with degenerative jointdisease.[2] It acts as aCOX-2 inhibitor.[3]
Mavacoxib, along with several other COX-2 selective inhibitors, includingcelecoxib,valdecoxib, andparecoxib, were discovered by a team at theSearle division ofMonsanto led byJohn Talley.[4][5]
{{cite journal}}: CS1 maint: overridden setting (link){{cite news}}: CS1 maint: overridden setting (link)Thisveterinary medicine–related article is astub. You can help Wikipedia byadding missing information. |
Thisdrug article relating to themusculoskeletal system is astub. You can help Wikipedia byadding missing information. |